Hybridization chain reaction circuit controller: CRISPR/Cas12a conversion amplifier for miRNA-21 sensitive detection
- PMID: 37657377
- DOI: 10.1016/j.talanta.2023.125130
Hybridization chain reaction circuit controller: CRISPR/Cas12a conversion amplifier for miRNA-21 sensitive detection
Erratum in
-
Corrigendum to "Hybridization chain reaction circuit controller: CRISPR/Cas12a conversion amplifier for miRNA-21 sensitive detection" [Talanta 266 (2024) 125130].Talanta. 2024 Mar 1;269:125395. doi: 10.1016/j.talanta.2023.125395. Epub 2023 Nov 25. Talanta. 2024. PMID: 38006730 No abstract available.
Abstract
MicroRNA (miRNA) is crucial to the diagnose of various diseases. However, the accurate detection of miRNA has been challenging due to its short length and low abundance. Here, we designed a hybridization chain reaction (HCR) circuit controller to initiate the CRISPR/Cas12a conversion amplifier (HCR-Cas12a controller) for sensitive detection of miRNA-21 (miR-21). In the HCR, pre-crRNA was encapsulated in a hairpin structure until the miR-21 was present. Afterward, Cas12a fully exerted its RNase activity to self-mature pre-crRNA. Then, the trans-cleavage activity of Cas12a was initiated by activator. This results in the conversion of biological signals to fluorescent signal. During HCR-Cas12a controller, the circuit formed quickly, while the Cas12a system worked in a short time. The miR-21 was ultra-sensitively detected with the wide detection range of 1 fM - 100 nM, and the calculated limit of detection was 75.4 aM. The sensitivity was an order of magnitude lower than the standard method. The formation of HCR at room temperature does not require a thermal cycler. Additionally, Cas12a can work without the need for precise or expensive instruments. Therefore, our proposed method was suitable for low-resource settings, and provided a technical basis for sensitive detection of miRNA in low concentration range.
Keywords: CRISPR/Cas; Diseases diagnose; Hybridization chain reaction (HCR); MicroRNA; Nucleic acid detection.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Mini crRNA-mediated CRISPR/Cas12a system (MCM-CRISPR/Cas12a) and its application in RNA detection.Talanta. 2024 Feb 1;268(Pt 1):125350. doi: 10.1016/j.talanta.2023.125350. Epub 2023 Oct 28. Talanta. 2024. PMID: 37922816
-
A programmable and sensitive CRISPR/Cas12a-based MicroRNA detection platform combined with hybridization chain reaction.Biosens Bioelectron. 2022 Sep 1;211:114382. doi: 10.1016/j.bios.2022.114382. Epub 2022 May 18. Biosens Bioelectron. 2022. PMID: 35605545
-
A colorimetric tandem combination of CRISPR/Cas12a with dual functional hybridization chain reaction for ultra-sensitive detection of Mycobacterium bovis.Anal Methods. 2024 May 23;16(20):3220-3230. doi: 10.1039/d3ay02200e. Anal Methods. 2024. PMID: 38717230
-
Application of CRISPR/Cas12a in the rapid detection of pathogens.Clin Chim Acta. 2023 Aug 1;548:117520. doi: 10.1016/j.cca.2023.117520. Epub 2023 Aug 16. Clin Chim Acta. 2023. PMID: 37595863 Review.
-
Detection of Parasites in the Field: The Ever-Innovating CRISPR/Cas12a.Biosensors (Basel). 2024 Mar 14;14(3):145. doi: 10.3390/bios14030145. Biosensors (Basel). 2024. PMID: 38534252 Free PMC article. Review.
Cited by
-
Nanotechnology-leveraged CRISPR/Cas systems: icebreaking in trace cancer-related nucleic acids biosensing.Mol Cancer. 2025 Mar 14;24(1):78. doi: 10.1186/s12943-024-02222-5. Mol Cancer. 2025. PMID: 40087758 Free PMC article. Review.
-
CRISPR detection of cardiac tumor-associated microRNAs.Mol Biol Rep. 2025 Jan 11;52(1):114. doi: 10.1007/s11033-024-10205-4. Mol Biol Rep. 2025. PMID: 39797940 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources